Skip to main content
PMC home page
Gut logoLink to Gut
. 1982 Jun;23(6):545–551. doi: 10.1136/gut.23.6.545

Comparison between cimetidine and Caved-S in the treatment of gastric ulceration, and subsequent maintenance therapy.

A G Morgan, W A McAdam, C Pacsoo, A Darnborough
PMCID: PMC1419696  PMID: 7042486

Abstract

One hundred patients with benign gastric ulceration were treated in a single-blind, endoscopically controlled trial to assess the relative efficacy of cimetidine (1 g daily) and Caved-S (six tablets daily). Ulcer healing was assessed after six weeks' treatment, and, if incomplete, after a further six weeks. There was no significant difference between the two drug regimens (approximately 63% at six weeks and 91% at 12 weeks). If an ulcer remains unhealed after 10 weeks' treatment the patient should undergo surgery. There was no difference in the relief of day pain between the two drug regimens but cimetidine was more effective over the first two weeks of treatment relieving night pain, than was Caved-S (p less than 0 . 02). After ulcer healing, drug dosage was reduced (cimetidine to 400 mg at night and Caved-S to two tablets twice daily). So far, 56 patients, 28 in each group, have completed the first year's maintenance treatment, and there have been four ulcer recurrences in each group (14%).

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bardhan K. D., Cumberland D. C., Dixon R. A., Holdsworth C. D. Clinical trial of deglycyrrhizinised liquorice in gastric ulcer. Gut. 1978 Sep;19(9):779–782. doi: 10.1136/gut.19.9.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bennett A., Clark-Wibberley T., Stamford I. F., Wright J. E. Aspirin-induced gastric mucosal damage in rats: cimetidine and deglycyrrhizinated liquorice together give greater protection than low doses of either drug alone. J Pharm Pharmacol. 1980 Feb;32(2):151–151. doi: 10.1111/j.2042-7158.1980.tb12879.x. [DOI] [PubMed] [Google Scholar]
  3. Ciclitira P. J., Machell R. J., Farthing J. G., Dick A. P., Hunter J. O. Double-blind controlled trial of cimetidine in the healing of gastric ulcer. Gut. 1979 Aug;20(8):730–734. doi: 10.1136/gut.20.8.730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Davies G. J., Rhodes J., Calcraft B. J. Complications of carbenoxolone therapy. Br Med J. 1974 Aug 10;3(5927):400–402. doi: 10.1136/bmj.3.5927.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Frost F., Rahbek I., Rune S. J., Jensen K. B., Gudmand-Hoyer E., Krag E., Rask-Madsen J., Wulff H. R., Garbol J., Jensen K. G. Cimetidine in patients with gastric ulcer: a multicentre controlled trial. Br Med J. 1977 Sep 24;2(6090):795–797. doi: 10.1136/bmj.2.6090.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hanscom D. H., Buchman E. The Veterans Administration Cooperative Study on Gastric Ulcer. 4. The follow-up period. Gastroenterology. 1971 Oct;61(4 Suppl):585–591. [PubMed] [Google Scholar]
  7. Hunt P. S., Hansky J., Korman M. G. Mortality in patients with haematemesis and melaena: a prospective study. Br Med J. 1979 May 12;1(6173):1238–1240. doi: 10.1136/bmj.1.6173.1238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jensen K. B., Møllmann K. M., Rahbek I., Madsen J. R., Rune S. J., Wulff H. R. Prophylactic effect of cimetidine in gastric ulcer patients. Scand J Gastroenterol. 1979;14(2):175–176. doi: 10.3109/00365527909179865. [DOI] [PubMed] [Google Scholar]
  9. Jones P. F., Johnston S. J., McEwan A. B., Kyle J., Needham C. D. Further haemorrhage after admission to hospital for gastrointestinal haemorrhage. Br Med J. 1973 Sep 29;3(5882):660–664. doi: 10.1136/bmj.3.5882.660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Machell R. J., Ciclitira P. J., Farthing M. J., Dick A. P., Hunter J. O. Cimetidine in the prevention of gastric ulcer relapse. Postgrad Med J. 1979 Jun;55(644):393–395. doi: 10.1136/pgmj.55.644.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Morgan A. G., McAdam W. A., Pacsoo C., Walker B. E., Simmons A. V. Cimetidine: an advance in gastric ulcer treatment? Br Med J. 1978 Nov 11;2(6148):1323–1326. doi: 10.1136/bmj.2.6148.1323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Morris T. J., Calcraft B. J., Rhodes J., Hole D., Morton M. S. Effect of a deglycyrrhizinised liquorice compound on the gastric mucosal barrier of the dog. Digestion. 1974;11(5-6):355–363. doi: 10.1159/000197603. [DOI] [PubMed] [Google Scholar]
  13. Mountford R. A., Brown P., Salmon P. R., Alvarenga C., Neumann C. S., Read A. E. Gastric cancer detection in gastric ulcer disease. Gut. 1980 Jan;21(1):9–17. doi: 10.1136/gut.21.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Murray J. R. Bismuth neurotoxicity. Med J Aust. 1978 Mar 11;1(5):279–280. doi: 10.5694/j.1326-5377.1978.tb112545.x. [DOI] [PubMed] [Google Scholar]
  15. Muscroft T. J., Youngs D. J., Burdon D. W., Keighley M. R. Cimetidine is unlikely to increase formation of intragastric N-nitroso-compounds in patients taking a normal diet. Lancet. 1981 Feb 21;1(8217):408–410. doi: 10.1016/s0140-6736(81)91791-8. [DOI] [PubMed] [Google Scholar]
  16. Piper D. W., Greig M., Coupland G. A., Hobbin E., Shinners J. Factors relevant to the prognosis of chronic gastric ulcer. Gut. 1975 Sep;16(9):714–718. doi: 10.1136/gut.16.9.714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rees W. D., Rhodes J., Wright J. E., Stamford L. F., Bennett A. Effect of deglycyrrhizinated liquorice on gastric mucosal damage by aspirin. Scand J Gastroenterol. 1979;14(5):605–607. doi: 10.3109/00365527909181397. [DOI] [PubMed] [Google Scholar]
  18. Schiller K. F., Truelove S. C., Williams D. G. Haematemesis and melaena, with special reference to factors influencing the outcome. Br Med J. 1970 Apr 4;2(5700):7–14. doi: 10.1136/bmj.2.5700.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Supino-Viterbo V., Sicard C., Risvegliato M., Rancurel G., Buge A. Toxic encephalopathy due to ingestion of bismuth salts: clinical and EEG studies of 45 patients. J Neurol Neurosurg Psychiatry. 1977 Aug;40(8):748–752. doi: 10.1136/jnnp.40.8.748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Symons A. M., Parke D. V. The effects of sodium carbenoxolone on the stability of cellular membranes. Scand J Gastroenterol Suppl. 1980;65:3–10. [PubMed] [Google Scholar]
  21. Taylor R. H., Menzies-Gow N., Lovell D., La Brooy S. J., Misiewicz J. J. Misleading response of malignant gastric ulcers to cimetidine. Lancet. 1978 Apr 1;1(8066):686–688. doi: 10.1016/s0140-6736(78)90799-7. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES